StockMacro
Menu

CME

$307.56 +8.9% in 6 monthsMarket cap $110.1B

CME on XNAS, Financials, CME Group Inc., job postings

Measures activity, not value. Not investment advice.

Net income rose 17% to $4.4B over 12 months as quarterly revenue rose 13% to $1.7B.

  • WatchCapital spending fell 14% to $15.8M in the latest quarter

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Industry
Security & commodity brokers, dealers, exchanges & services (Financials)
Employees
3,875
Website
cmegroup.com
Listed
Nasdaq, US
Last results
21 Oct 2026
Next results
expected around 3 Feb 2027 (an estimate: a year ago it reported on 4 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.7B, net income $1.0B.
Quarter to 31 Dec 2021: revenue $1.1B, net income $625.2MQuarter to 31 Dec 2021: revenue $1.1B, net income $625.2MQuarter to 31 Mar 2022: revenue $1.3B, net income $711.0MQuarter to 31 Mar 2022: revenue $1.3B, net income $711.0MQuarter to 30 Jun 2022: revenue $1.2B, net income $662.5MQuarter to 30 Jun 2022: revenue $1.2B, net income $662.5MQuarter to 30 Sep 2022: revenue $1.2B, net income $679.6MQuarter to 30 Sep 2022: revenue $1.2B, net income $679.6MQuarter to 31 Dec 2022: revenue $1.2B, net income $637.9MQuarter to 31 Dec 2022: revenue $1.2B, net income $637.9MQuarter to 31 Mar 2023: revenue $1.4B, net income $883.8MQuarter to 31 Mar 2023: revenue $1.4B, net income $883.8MQuarter to 30 Jun 2023: revenue $1.4B, net income $777.6MQuarter to 30 Jun 2023: revenue $1.4B, net income $777.6MQuarter to 30 Sep 2023: revenue $1.3B, net income $750.2MQuarter to 30 Sep 2023: revenue $1.3B, net income $750.2MQuarter to 31 Dec 2023: revenue $1.4B, net income –Quarter to 31 Mar 2024: revenue $1.5B, net income $855.2MQuarter to 31 Mar 2024: revenue $1.5B, net income $855.2MQuarter to 30 Jun 2024: revenue $1.5B, net income $883.2MQuarter to 30 Jun 2024: revenue $1.5B, net income $883.2MQuarter to 30 Sep 2024: revenue $1.6B, net income $912.8MQuarter to 30 Sep 2024: revenue $1.6B, net income $912.8MQuarter to 31 Dec 2024: revenue $1.5B, net income –Quarter to 31 Mar 2025: revenue $1.6B, net income $956.2MQuarter to 31 Mar 2025: revenue $1.6B, net income $956.2MQuarter to 30 Jun 2025: revenue $1.7B, net income $1.0BQuarter to 30 Jun 2025: revenue $1.7B, net income $1.0BQuarter to 30 Sep 2025: revenue $1.5B, net income $908.0MQuarter to 30 Sep 2025: revenue $1.5B, net income $908.0MQuarter to 31 Dec 2025: revenue $1.6B, net income $1.2BQuarter to 31 Dec 2025: revenue $1.6B, net income $1.2BQuarter to 31 Mar 2026: revenue $1.9B, net income $1.2BQuarter to 31 Mar 2026: revenue $1.9B, net income $1.2BQuarter to 30 Jun 2026: revenue $1.7B, net income $1.0BQuarter to 30 Jun 2026: revenue $1.7B, net income $1.0BQuarter to 30 Sep 2026: revenue $1.7B, net income $1.0BQuarter to 30 Sep 2026: revenue $1.7B, net income $1.0B
31 Dec 2021RevenueNet incometallest bar $1.9B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.7B$1.0B
30 Jun 2026$1.7B$1.0B
31 Mar 2026$1.9B$1.2B
31 Dec 2025$1.6B$1.2B
30 Sep 2025$1.5B$908.0M
30 Jun 2025$1.7B$1.0B
31 Mar 2025$1.6B$956.2M
31 Dec 2024$1.5B–
30 Sep 2024$1.6B$912.8M
30 Jun 2024$1.5B$883.2M
31 Mar 2024$1.5B$855.2M
31 Dec 2023$1.4B–
30 Sep 2023$1.3B$750.2M
30 Jun 2023$1.4B$777.6M
31 Mar 2023$1.4B$883.8M
31 Dec 2022$1.2B$637.9M
30 Sep 2022$1.2B$679.6M
30 Jun 2022$1.2B$662.5M
31 Mar 2022$1.3B$711.0M
31 Dec 2021$1.1B$625.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +9.5%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $4.4B $3.8B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $12.19 $10.32
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 49.8%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – 4.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – 10.0%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 16.1% 17.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $4.3B $4.1B
CashCash, cash equivalents and short-term investments on the latest balance sheet. – –
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. –
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 24.9 23.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 1.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. –
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 4.1 4.1
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 1.6% 0.75%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small. Cash, debt and EV/Sales are not shown for banks, insurers and investment companies.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CMECME (this company) $110.1B24.9–––
Intercontinental ExchangeICE $95.0B22.8–––
NasdaqNDAQ $57.1B27.4–––
Cboe Global MarketsCBOE $37.3B25.2–––
Tradeweb MarketsTW $26.4B29.1–––
LPL FinancialLPLA $20.6B14.81.0+31%6.8%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$18.2M

bought $79K, sold $18.3M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.3%

1,739 13F filers vs 1,668

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

–

No 13F holdings or share count.

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

–

5.4M shares sold short (30 Oct 2026); no share count in the company's filings in our data

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.4

5.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+7.3%

5.0M shares sold short in the report before, 5.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

57%

57% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

79

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+13%

$1.7B vs $1.5B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-14%

$15.8M vs $18.4M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$1.9M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

165

165 articles in the last 7 days; its usual week has 9 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

18×

165 articles in the last 7 days; its usual week has 9.

Price $307.56 on 20 Nov 2026, +12% over 12 months (12-month range $218.58 to $326.46)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $41.2M in the last 12 months (the 12 months before: -$25.7M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 19 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $1.7B in the latest quarter, +13% on a year earlier.
Capital spending per quarter. Capital spending $15.8M in the latest quarter, -14% on a year earlier.
Institutional holders (13F filers). 1,739 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.
Lobbying spend. Lobbying spend: $1.9M published in the last 12 months, +6.1% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 Sep 20268-K and other filingsDirector or officer change
21 Jul 2026Sharp changeLobbying spend jump: lobbying spend jump, 620K vs usual 425K (2026-06-30); 1.4x the same period a year earlier
17 Jun 20268-K and other filingsDirector or officer change
17 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 152 vs usual 104.50 (2026-03-31); 0.9x the same period a year earlier
20 Jan 2026Sharp changeLobbying on a new issue: lobbying on a new issue: DEF (2025-12-31)
2 Dec 2025Sharp changeWikipedia attention spike: wikipedia attention spike, 6,552 vs usual 1,886 (2025-11-24..2025-11-30); 3.3x the same week a year earlier
11 Sep 20258-K and other filingsDirector or officer change
11 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 141 vs usual 98 (2025-06-30); 1.5x the same period a year earlier
15 May 2025Sharp changeMany funds opening a new position: many funds opening a new position, 165 vs usual 98 (2025-03-31); 1.7x the same period a year earlier
21 Jan 2025Sharp changeLobbying spend jump: lobbying spend jump, 540K vs usual 355K (2024-12-31); 1.6x the same period a year earlier
7 Nov 20248-K and other filingsDirector or officer change
7 Nov 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Jul 20248-K and other filingsDirector or officer change
8 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Jul 2024Sharp changeShort interest spike: short interest spike, 6.0M vs usual 3.8M (2024-06-14); 1.4x the same period a year earlier
7 Mar 20248-K and other filingsDirector or officer change
7 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Dec 20238-K and other filingsDirector or officer change
13 Nov 20238-K and other filingsDirector or officer change
13 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Mar 20238-K and other filingsDirector or officer change
10 Mar 20238-K and other filingsDirector or officer change
28 Feb 20238-K and other filingsDirector or officer change
28 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Nov 2022Sharp changeWikipedia attention spike: wikipedia attention spike, 7,055 vs usual 1,763 (2022-11-21..2022-11-27); 3.6x the same week a year earlier
26 Jul 2022Sharp changeLobbying spend jump: lobbying spend jump, 440K vs usual 270K (2022-06-30); 1.7x the same period a year earlier
25 May 2022Lobbying filingnew lobbying registration (THE RUSSELL GROUP, INC.)
14 Apr 20228-K and other filingsDirector or officer change
17 Feb 20228-K and other filingsDirector or officer change
3 Feb 20228-K and other filingsDirector or officer change
3 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$1.1M published
Month from 1 Feb 2022: -$5.8M published
Month from 1 Mar 2022: -$3.2M published
Month from 1 Aug 2022: -$999K published
Month from 1 Sep 2022: -$1.1M published
Month from 1 Nov 2022: $8.3M published
Month from 1 Dec 2022: $265K published
Month from 1 Jan 2023: $279K published
Month from 1 Mar 2023: $94K published
Month from 1 Jun 2023: $58K published
Month from 1 Jul 2023: -$3.9M published
Month from 1 Aug 2023: -$9.9M published
Month from 1 Oct 2023: -$442K published
Month from 1 Nov 2023: -$572K published
Month from 1 Dec 2023: -$3.9M published
Month from 1 Jan 2024: $281K published
Month from 1 Mar 2024: -$65K published
Month from 1 May 2024: -$10.7M published
Month from 1 Jun 2024: -$654K published
Month from 1 Sep 2024: -$1.7M published
Month from 1 Oct 2024: -$1.6M published
Month from 1 Nov 2024: -$259K published
Month from 1 Dec 2024: $64K published
Month from 1 Jan 2025: $326K published
Month from 1 Feb 2025: -$4.2M published
Month from 1 Mar 2025: -$12.1M published
Month from 1 Apr 2025: -$1.1M published
Month from 1 May 2025: -$3.0M published
Month from 1 Jun 2025: -$60K published
Month from 1 Aug 2025: -$3.2M published
Month from 1 Sep 2025: -$226K published
Month from 1 Nov 2025: -$2.2M published
Month from 1 Dec 2025: -$6.7M published
Month from 1 Jan 2026: $73K published
Month from 1 Feb 2026: -$1.6M published
Month from 1 Mar 2026: -$2.6M published
Month from 1 May 2026: -$12.2M published
Month from 1 Jun 2026: $78K published
Month from 1 Sep 2026: -$4.2M published
Month from 1 Oct 2026: -$1.6M published
Month from 1 Nov 2026: -$12.4M published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 19 published
Revenue per quarter
Quarter ended 31 Dec 2021: $1.1B, +4.4% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $1.3B, +7.4% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $1.2B, +4.9% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $1.2B, +11% on a year earlier; public on 3 Nov 2022
Quarter ended 31 Dec 2022: $1.2B, +5.3% on a year earlier; public on 28 Feb 2023
Quarter ended 31 Mar 2023: $1.4B, +7.1% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $1.4B, +9.9% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $1.3B, +9.0% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $1.4B, +19% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $1.5B, +3.2% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $1.5B, +13% on a year earlier; public on 6 Aug 2024
Quarter ended 30 Sep 2024: $1.6B, +18% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $1.5B, +6.0% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $1.6B, +10% on a year earlier; public on 1 May 2025
Quarter ended 30 Jun 2025: $1.7B, +10% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $1.5B, -3.0% on a year earlier; public on 25 Oct 2025
Quarter ended 31 Dec 2025: $1.6B, +8.1% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $1.9B, +14% on a year earlier; public on 25 Apr 2026
Quarter ended 30 Jun 2026: $1.7B, +0.8% on a year earlier; public on 25 Jul 2026
Quarter ended 30 Sep 2026: $1.7B, +13% on a year earlier; public on 24 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $27.3M, -61% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $23.4M, -18% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $17.9M, -55% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $24.0M, -24% on a year earlier; public on 3 Nov 2022
Quarter ended 31 Dec 2022: $24.4M, -11% on a year earlier; public on 28 Feb 2023
Quarter ended 31 Mar 2023: $15.2M, -35% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $20.5M, +15% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $19.9M, -17% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $20.8M, -15% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $19.8M, +30% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $18.2M, -11% on a year earlier; public on 6 Aug 2024
Quarter ended 30 Sep 2024: $29.8M, +50% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $26.2M, +26% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $14.2M, -28% on a year earlier; public on 1 May 2025
Quarter ended 30 Jun 2025: $18.4M, +1.1% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $18.4M, -38% on a year earlier; public on 25 Oct 2025
Quarter ended 31 Dec 2025: $32.5M, +24% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $21.8M, +54% on a year earlier; public on 25 Apr 2026
Quarter ended 30 Jun 2026: $23.6M, +28% on a year earlier; public on 25 Jul 2026
Quarter ended 30 Sep 2026: $15.8M, -14% on a year earlier; public on 24 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 1,015; public on 14 Feb 2022
31 Mar 2022 report: 1,107; public on 16 May 2022
30 Jun 2022 report: 1,079; public on 15 Aug 2022
30 Sep 2022 report: 1,031; public on 14 Nov 2022
31 Dec 2022 report: 1,048; public on 14 Feb 2023
31 Mar 2023 report: 1,088; public on 15 May 2023
30 Jun 2023 report: 1,090; public on 14 Aug 2023
30 Sep 2023 report: 1,125; public on 14 Nov 2023
31 Dec 2023 report: 1,252; public on 14 Feb 2024
31 Mar 2024 report: 1,296; public on 15 May 2024
30 Jun 2024 report: 1,295; public on 14 Aug 2024
30 Sep 2024 report: 1,314; public on 14 Nov 2024
31 Dec 2024 report: 1,414; public on 14 Feb 2025
31 Mar 2025 report: 1,508; public on 15 May 2025
30 Jun 2025 report: 1,590; public on 14 Aug 2025
30 Sep 2025 report: 1,567; public on 14 Nov 2025
31 Dec 2025 report: 1,642; public on 17 Feb 2026
31 Mar 2026 report: 1,743; public on 15 May 2026
30 Jun 2026 report: 1,668; public on 14 Aug 2026
30 Sep 2026 report: 1,739; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $280K published
Quarter from 1 Apr 2022: $320K published
Quarter from 1 Jul 2022: $440K published
Quarter from 1 Oct 2022: $350K published
Quarter from 1 Jan 2023: $320K published
Quarter from 1 Apr 2023: $350K published
Quarter from 1 Jul 2023: $430K published
Quarter from 1 Oct 2023: $350K published
Quarter from 1 Jan 2024: $340K published
Quarter from 1 Apr 2024: $360K published
Quarter from 1 Jul 2024: $420K published
Quarter from 1 Oct 2024: $380K published
Quarter from 1 Jan 2025: $540K published
Quarter from 1 Apr 2025: $430K published
Quarter from 1 Jul 2025: $440K published
Quarter from 1 Oct 2025: $390K published
Quarter from 1 Jan 2026: $400K published
Quarter from 1 Apr 2026: $430K published
Quarter from 1 Jul 2026: $620K published
Quarter from 1 Oct 2026: $460K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $8.6M (19 Nov 2026), 22× its normal reading; higher than 100% of its own history.
  • Lobbying spend jump: reported $620K of lobbying spend for the quarter ended 30 Jun 2026, 1.4× the same quarter last year Public on 20 Jul 2026.
  • Insider net buying (open market): Insiders sold a net $41.2M in the last 12 months (the 12 months before: -$25.7M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 19 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 9 sales, $18.3M; 1 purchase, $79K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
19 Nov 2026John Clifford MarcheseSr MD, General CounselSell655$310.75$204KForm 4
19 Nov 2026Terrence A DuffyChairman and CEOSell27,000$309.57$8.4MForm 4
10 Nov 2026Daniel G KayeDirectorSell532$304.17$162KForm 4
3 Nov 2026Howard J SiegelDirectorSell2,000$303.00$606KForm 4
2 Nov 2026Julie WinklerSr MD Chief Commercial OfficerSell10,079$305.15$3.1MForm 4
27 Oct 2026Sunil CutinhoChief Information OfficerSell5,000$298.70$1.5MForm 4
22 Oct 2026Martin J GepsmanDirectorSell400$302.50$121KForm 4
28 Sep 2026William R ShepardDirectorBuy293$268.76$79KForm 4

1,739 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 172 opened a position, 104 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.30.1M45.2%$7.9B-417K-1.4%
Vanguard Capital Management LLC23.5M35.3%$6.2B-121K-0.5%
State Street Corp16.2M24.4%$4.3B-118K-0.7%
Morgan Stanley10.1M15.2%$2.7B+414K+4.3%
Geode Capital Management, LLC9.4M14.1%$2.5B+121K+1.3%
Vanguard Portfolio Management LLC9.3M13.9%$2.4B+83K+0.9%
JPMorgan Chase & Co9.2M13.7%$2.4B+3.4M+59%
Capital World Investors7.5M11.3%$2.0B+720K+11%
Sanders Capital, LLC5.1M7.59%$1.3B-8,875-0.2%
Ameriprise Financial Inc4.4M6.56%$1.1B+11K+0.3%

Federal contracts

All 1 federal contracts

No new award in 12 months; the latest was signed 1 Sep 2009. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
1 Sep 2009Department of DefenseDepartment of the Air Force$2.7MADVANCES IN BIOTECHNOLOGY AND THE BIOSCIENCES FOR WARFIGHTER PERFORMANCE AND PROTECTIONUSAspending

Company events

All 46 company events

In 12 months: 2 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
9 Sep 2026Director or officer change8-K
17 Jun 2026Director or officer change8-K
27 Apr 2026Signed a major agreement8-K
11 Sep 2025Director or officer change8-K
25 Apr 2025Signed a major agreementSame filing: took on new debt8-K
10 Mar 2025Signed a major agreement8-K
7 Nov 2024Director or officer change8-K
8 Jul 2024Director or officer change8-K

79 open postings; careers site tracked since 20 Nov 2026. Most in Security 16%, SRE, DevOps & infrastructure 11%, Data & analytics 6%, Legal, policy & compliance 5%.

PostedJobLocation
21 Nov 2026Desktop Support Intern - Year-RoundCorporate ITChicago - 20 S. Wacker
20 Nov 2026or earlierSenior BLM AnalystChicago - 20 S. Wacker
20 Nov 2026or earlierPost-Trade Services & Risk Associate – IndiaBangalore - Bagmane Tridib
20 Nov 2026or earlierSite Reliability Engineer III (Multiple Openings)SRE, DevOps & infrastructureChicago - 20 S. Wacker
20 Nov 2026or earlierSite Reliability Engineer IIISRE, DevOps & infrastructureBelfast - Millennium House
20 Nov 2026or earlierStaff Data Reliability Engineer - IndiaTest, quality & reliabilityBangalore - Bagmane Tridib
20 Nov 2026or earlierMgr CD&S - BuysideHong Kong - Man Yee Building
20 Nov 2026or earlierManager - Workday HCMBangalore - Bagmane Tridib

Reported lobbying spend: $460K in Q3 2026, $620K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
15 Apr 2022NewThe Russell Group, Inc.for Cme Group, Inc.Futures industry issuesAgricultureFiling
30 Jun 2020EndedDavis & Harman LLPfor Cme GroupTax issues relating to futures transactions, including those designed to curb excess commodities speculation. Proposals that would require ordinary tax treatment for certain dealers of equity options and commodities. Proposals related to carried interest.TaxationFiling
31 Dec 2018EndedMccarty Financial LLCfor Nex Services North America LLC -Formerly Intercapital Services North America LLCPost Trade Risk Reduction Services and regulatory treatment; SEF Rules related to Post Trade Risk Reduction; Margin on Uncleared Swaps Rules; SEF listing and trading of cryptocurrency products; US Treasury Market Structure issues related to trading and reporting cash US Treasury Transactions.BANFiling
1 Jan 2018EndedDelta Strategy Groupfor Cme GroupNot statedFiling
1 Jan 2017NewMccarty Financial LLCfor Nex Services North America LLC -Formerly Intercapital Services North America LLCFinancial services policy and regulation; fintech legislation and regulation including blockchain; U.S. Treasury market structure issues.BAN, Financial institutionsFiling
31 Dec 2014EndedWilliams And Jensen, PLLCfor Cme GroupTax issues affecting futures trading, and Transaction Fee Proposals; Tax Reform issues.; Dodd-Frank Act regulations; financial services; CFTC regulation; OTC trading; swaps trading and Speculation in Energy Commodities. CFTC/CEA Reauthorization; H.R. 4413Taxation, CDTFiling
30 Jan 2009EndedFoley & Lardner LLPfor Cme GroupLegislation and regulations affecting futures markets; Commodity Exchange Act issuesEnergy, AgricultureFiling
20 Oct 2008NewDelta Strategy Groupfor Cme GroupMonitor all issues pertaining to the commodity futures exchange and CFTC reauthorization.Financial institutionsFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 May 2012. State WARN notices.

NoticeSiteWorkersJobs endSource
1 May 2012CME GroupMonmouth Junction, NJ1102 Jul 2012Notice

The 5 newest of 880 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 29 Sep 2026Insiders record

    SHEPARD WILLIAM R (director) bought 293 shares of CME ($78,626) (dated 28 Sep 2026)

  2. 9 Sep 2026Filings record

    Director or officer change

  3. 20 Jul 2026Lobbying change

    reported $620K of lobbying spend for the quarter ended 30 Jun 2026, 1.4× the same quarter last year.

    Same quarter last year: $440K; its normal quarter is $425K.

    See the evidence
    This period
    $620K (the quarter ended 30 Jun 2026)
    Normal quarter (median of 8 earlier)
    $425K
    Typical spread (median absolute deviation)
    $20K
    How far from its usual level
    +4.6
    Same quarter last year
    $440K
    History used
    6,574 days
    2024-06-30: $420K2024-09-30: $380K2024-12-31: $540K2025-03-31: $430K2025-06-30: $440K2025-09-30: $390K2025-12-31: $400K2026-03-31: $430K2026-06-30: $620K
    the quarter ended 30 Jun 20268 earlier quartersnormal: $425K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  4. 30 Jun 2026Insiders record

    SHEPARD WILLIAM R (director) bought 339 shares of CME ($78,186) (dated 29 Jun 2026)

  5. 17 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 17 Jun 2026Filings record

    Director or officer change

  7. 15 May 2026Institutional holdings change

    saw 152 13F filers open a new position in the quarter ended 31 Mar 2026, 7.9% below the same quarter last year.

    Same quarter last year: 165; its normal quarter is 104.

    See the evidence
    This period
    152 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    104
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +4.5
    Same quarter last year
    165
    History used
    4,565 days
    2024-03-31: 972024-06-30: 962024-09-30: 992024-12-31: 1042025-03-31: 1652025-06-30: 1412025-09-30: 1052025-12-31: 1082026-03-31: 152
    the quarter ended 31 Mar 20268 earlier quartersnormal: 104

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  8. 31 Mar 2026Insiders record

    SHEPARD WILLIAM R (director) bought 1,470 shares of CME ($437,101) (dated 30 Mar 2026)

  9. 20 Jan 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['DEF']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12768509
  10. 3 Jan 2026Insiders record

    SHEPARD WILLIAM R (director) bought 262 shares of CME ($73,008) (dated 2 Jan 2026)

  11. 2 Dec 2025Attention change

    drew 6,552 Wikipedia page views in the week of 24 Nov 2025, 3.3× the same week last year.

    Same week last year: 2,010; its normal week is 1,886.

    See the evidence
    This period
    6,552 (the week of 24 Nov 2025)
    Normal week (median of 26 earlier)
    1,886
    Typical spread (median absolute deviation)
    184
    How far from its usual level
    +17.1
    Same week last year
    2,010
    History used
    2,525 days
    2025-05-26: 1,6582025-06-02: 1,5052025-06-09: 1,5052025-06-16: 1,6312025-06-23: 1,5552025-06-30: 1,3322025-07-07: 1,7322025-07-14: 2,1922025-07-21: 1,9612025-07-28: 1,7562025-08-04: 1,7092025-08-11: 1,7022025-08-18: 2,1042025-08-25: 1,8322025-09-01: 1,8852025-09-08: 1,9802025-09-15: 2,0712025-09-22: 1,8732025-09-29: 2,4102025-10-06: 2,1242025-10-13: 2,0692025-10-20: 1,8872025-10-27: 2,4992025-11-03: 1,9692025-11-10: 1,9812025-11-17: 2,8292025-11-24: 6,552
    the week of 24 Nov 202526 earlier weeksnormal: 1,886

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  12. 13 Nov 2025Institutional holdings record

    Sanders Capital, LLC opened a $1.0B position (2025Q3 13F)

  13. 27 Sep 2025Insiders record

    SHEPARD WILLIAM R (director) bought 274 shares of CME ($72,673) (dated 26 Sep 2025)

  14. 11 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 11 Sep 2025Filings record

    Director or officer change

  16. 14 Aug 2025Institutional holdings change

    saw 141 13F filers open a new position in the quarter ended 30 Jun 2025, 1.5× the same quarter last year.

    Same quarter last year: 96; its normal quarter is 98.

    See the evidence
    This period
    141 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    98
    Typical spread (median absolute deviation)
    8
    How far from its usual level
    +3.6
    Same quarter last year
    96
    History used
    4,291 days
    2023-06-30: 792023-09-30: 862023-12-31: 1082024-03-31: 972024-06-30: 962024-09-30: 992024-12-31: 1042025-03-31: 1652025-06-30: 141
    the quarter ended 30 Jun 20258 earlier quartersnormal: 98

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  17. 27 Jun 2025Insiders record

    SHEPARD WILLIAM R (director) bought 267 shares of CME ($72,337) (dated 26 Jun 2025)

  18. 15 May 2025Institutional holdings change

    saw 165 13F filers open a new position in the quarter ended 31 Mar 2025, 1.7× the same quarter last year.

    Same quarter last year: 97; its normal quarter is 98.

    See the evidence
    This period
    165 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    98
    Typical spread (median absolute deviation)
    8
    How far from its usual level
    +5.6
    Same quarter last year
    97
    History used
    4,200 days
    2023-03-31: 1082023-06-30: 792023-09-30: 862023-12-31: 1082024-03-31: 972024-06-30: 962024-09-30: 992024-12-31: 1042025-03-31: 165
    the quarter ended 31 Mar 20258 earlier quartersnormal: 98

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  19. 28 Mar 2025Insiders record

    SHEPARD WILLIAM R (director) bought 1,422 shares of CME ($324,198) [amended] (dated 27 Mar 2025)

  20. 28 Mar 2025Insiders record

    SHEPARD WILLIAM R (director) bought 274 shares of CME ($71,995) (dated 27 Mar 2025)

  21. 21 Jan 2025Lobbying change

    reported $540K of lobbying spend for the quarter ended 31 Dec 2024, 1.6× the same quarter last year.

    Same quarter last year: $340K; its normal quarter is $355K.

    See the evidence
    This period
    $540K (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $355K
    Typical spread (median absolute deviation)
    $20K
    How far from its usual level
    +5.2
    Same quarter last year
    $340K
    History used
    5,754 days
    2022-12-31: $320K2023-03-31: $350K2023-06-30: $430K2023-09-30: $350K2023-12-31: $340K2024-03-31: $360K2024-06-30: $420K2024-09-30: $380K2024-12-31: $540K
    the quarter ended 31 Dec 20248 earlier quartersnormal: $355K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  22. 18 Jan 2025Insiders record

    SHEPARD WILLIAM R (director) bought 1,429 shares of CME ($325,798) (dated 17 Jan 2025)

  23. 31 Dec 2024Insiders record

    SHEPARD WILLIAM R (director) bought 276 shares of CME ($64,285) (dated 30 Dec 2024)

  24. 7 Nov 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 7 Nov 2024Filings record

    Director or officer change

  26. 28 Sep 2024Insiders record

    SHEPARD WILLIAM R (director) bought 293 shares of CME ($63,946) (dated 27 Sep 2024)

  27. 8 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 8 Jul 2024Filings record

    Director or officer change

  29. 27 Jun 2024Short interest and volume change

    had 6.0M shares sold short in the 14 Jun 2024 report, 1.4× the same report last year.

    Same report last year: 4.1M; its normal report is 3.8M.

    See the evidence
    This period
    6.0M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    259K
    How far from its usual level
    +5.7
    Same report last year
    4.1M
    History used
    2,359 days
    2023-06-15: 4.1M2023-06-30: 4.0M2023-07-14: 4.3M2023-07-31: 4.3M2023-08-15: 4.0M2023-08-31: 3.8M2023-09-15: 3.5M2023-09-29: 3.7M2023-10-13: 4.1M2023-10-31: 3.6M2023-11-15: 3.4M2023-11-30: 3.5M2023-12-15: 3.9M2023-12-29: 4.1M2024-01-12: 3.8M2024-01-31: 3.4M2024-02-15: 3.0M2024-02-29: 3.3M2024-03-15: 3.7M2024-03-28: 4.4M2024-04-15: 3.5M2024-04-30: 3.4M2024-05-15: 3.9M2024-05-31: 5.1M2024-06-14: 6.0M
    the 14 Jun 2024 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 27 Jun 2024Insiders record

    SHEPARD WILLIAM R (director) bought 326 shares of CME ($63,569) (dated 26 Jun 2024)

  31. 28 Mar 2024Insiders record

    SHEPARD WILLIAM R (director) bought 294 shares of CME ($63,232) (dated 27 Mar 2024)

  32. 7 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 7 Mar 2024Filings record

    Director or officer change

  34. 20 Jan 2024Insiders record

    SHEPARD WILLIAM R (director) bought 1,390 shares of CME ($281,369) (dated 19 Jan 2024)

  35. 30 Dec 2023Insiders record

    SHEPARD WILLIAM R (director) bought 278 shares of CME ($58,646) (dated 29 Dec 2023)

  36. 6 Dec 2023Filings record

    Director or officer change

  37. 13 Nov 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 13 Nov 2023Filings record

    Director or officer change

  39. 7 Oct 2023Insiders record

    SHEPARD WILLIAM R (director) bought 292 shares of CME ($58,325) (dated 6 Oct 2023)

  40. 29 Jun 2023Insiders record

    SHEPARD WILLIAM R (director) bought 322 shares of CME ($57,972) (dated 28 Jun 2023)

Showing the newest 40 of 106 entries; narrow the window or the kind of data to see older ones.

Not listed: 399 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001156375
Ticker
CME
Domain
cmegroup.com
Employer name
Chicago Mercantile Exchange, Inc., CME Group, NEX Services North America LLC (3 unverified)
Fein
32-0485993, 36-4340266 (2 unverified)
Hq location
IL|CHICAGO|60606 (1 unverified)
Lobbying client
cme group
Name
Board of Trade of the City of Chicago, Inc, BrokerTec Americas LLC, BrokerTec Europe Limited, BrokerTec Holdings Inc and 50 more
Uei
DUVNFYH2ZPN3, L7LDU2NN4WC6
Wikidata
Q1023876
Wikipedia
CME Group
  • DOL H-1B labor condition applications and PERM certifications88 data points3 Nov 2025 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)14 records, 279 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings7 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)143 records5 Feb 2016 to 23 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)974 data points31 Dec 2006 to 30 Sep 2026
  • SEC Form 4 insider transactions312 records, 1032 data points23 Feb 2016 to 19 Nov 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1 record, 69 data points1 Sep 2009 to 3 Sep 2020
  • WARN layoff notices (state labor agencies)1 record, 3 data points30 Apr 2012 to 1 May 2012
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026